Ionis Pharmaceuticals AAQS 2024
Ionis Pharmaceuticals AAQS
4
Ticker
IONS
ISIN
US4622221004
WKN
A2ACMZ
Ionis Pharmaceuticals has a current AAQS of 4.
A high AAQS can be seen as a positive indicator that the company is developing successfully.
Investors can assume that the company is on a good path to generate profits.
On the other hand, it is important to consider the AAQS of the stock Ionis Pharmaceuticals in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.
In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.
Ionis Pharmaceuticals Aktienanalyse
What does Ionis Pharmaceuticals do?
Ionis Pharmaceuticals is a biotechnology company specializing in the development and marketing of RNA-based therapeutics for the treatment of various diseases. The company was founded in 1989 and is headquartered in Carlsbad, California. Ionis Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.Frequently Asked Questions about Ionis Pharmaceuticals stock
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Ionis Pharmaceuticals stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Ionis Pharmaceuticals
Our stock analysis for Ionis Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ionis Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Ionis Pharmaceuticals Revenue
- Ionis Pharmaceuticals Net Income
- Ionis Pharmaceuticals P/E
- Ionis Pharmaceuticals P/S
- Ionis Pharmaceuticals EBIT
- Ionis Pharmaceuticals Dividend
- Ionis Pharmaceuticals Stocks
- Ionis Pharmaceuticals Market capitalization
- Ionis Pharmaceuticals Debt
- Ionis Pharmaceuticals Liabilities
- Ionis Pharmaceuticals Equity
- Ionis Pharmaceuticals AAQS
- Ionis Pharmaceuticals Employees
- Ionis Pharmaceuticals ROE
- Ionis Pharmaceuticals ROA
- Ionis Pharmaceuticals ROCE